Brallobarbital

Brallobarbital
Clinical data
ATC code none
Identifiers
Synonyms Brallobarbital
CAS Number 561-86-4 YesY
PubChem (CID) 68416
ChemSpider 61699 YesY
UNII D0N7A2M3MU YesY
ChEMBL CHEMBL2106093 N
ECHA InfoCard 100.008.387
Chemical and physical data
Formula C10H11BrN2O3
Molar mass 287.110 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Brallobarbital is a barbiturate developed in the 1920s.[1] It has sedative and hypnotic properties, and was used for the treatment of insomnia. Brallobarbital was primarily sold as part of a combination product called Vesparax, composed of 150 mg secobarbital, 50 mg brallobarbital and 50 mg hydroxyzine.[2] The long half-life of this combination of drugs tended to cause a hangover effect the next day,[3] and Vesparax fell into disuse once newer drugs with lesser side effects had been developed.[4]

References

  1. US Patent 1869666
  2. Lhermann J. Clinical application of a new very active hypnotic associating sodium secobarbital, calcium brallobarbital and hydroxyzine (UC-8130). Gazette Medicale de France. 1964 Mar 10;71:961-2. (French)
  3. Yih TD, Rossum JM. Peculiar pharmacokinetics of brallobarbital as a source of complications in Vesparax intoxication. Xenobiotica. 1976 Jun;6(6):355-62.
  4. Fischbach R. Efficacy and safety of midazolam and vesparax in treatment of sleep disorders. British Journal of Clinical Pharmacology. 1983;16 Suppl 1:167S-171S.



This article is issued from Wikipedia - version of the 4/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.